A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability and Pharmacokinetics of Liraglutide in Obese Adolescent Subjects Aged 12 to 17 Years
Clinical trial NCT01789086 · COMPLETED
Trial details
- NCT number
- NCT01789086
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2014-05-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.